BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 129310)

  • 1. Lymphocytotoxins and mixed leucocyte culture blocking factor activity in the plasma of uraemic patients undergoing haemodialysis.
    Sengar DP; Rashid A; Perelmutter L; Harris JE
    Clin Exp Immunol; 1975 May; 20(2):249-55. PubMed ID: 129310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed leucocyte culture blocking factor activity in allograft recipients and its role in the clinical outcome of human cadaveric renal allografts.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Dec; 22(3):409-18. PubMed ID: 131667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Aug; 21(2):298-305. PubMed ID: 126831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of blood transfusions to appearance of mixed leukocyte culture blocking factor activity in plasma of uraemic patients and renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Vox Sang; 1974; 27(1):1-12. PubMed ID: 4277630
    [No Abstract]   [Full Text] [Related]  

  • 5. Mixed leucocyte culture blocking factor activity in the plasma of patients with cancer.
    Copeland D; Sengar DP; Rashid A; Perelmutter L; Stewart T; Harris J
    Oncology; 1974; 30(5):393-404. PubMed ID: 4282414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cell-mediated immunity in transfused uraemics.
    Dossetor JB; Kovithavongs T; Lao VS; Liburd EM; Lockwood JF; Schlaut J; Olson LA; Stiller CR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):455-63. PubMed ID: 4278129
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of blood transfusions on lymphocyte reactivity in man.
    Klatzmann D; Gluckman JC; Foucault C; Bedrossian J; Assogba U; Brisson E; Haguet M; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():453-9. PubMed ID: 6224210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MLC reactivity demonstrates transfusion-induced immunosuppression].
    Zingsem J; Weisbach V; Zeiler T; Zimmermann R; Wittmann G; Eckstein R
    Beitr Infusionsther Transfusionsmed; 1994; 32():293-6. PubMed ID: 9480111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The humoral responses of haemodialysis patients to antigen challenge.
    Castro JE; Mee AD
    Transplantation; 1976 Jul; 22(1):18-23. PubMed ID: 132722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejection.
    Shons AR; Etheredge EE; Callender CO; Schmidtke JR; Simmons RL; Najarian JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):464-70. PubMed ID: 4278196
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.
    Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC
    Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response.
    Burlingham WJ; Sparks EM; Sondel PM; Glass NR; Belzer FO; Sollinger HW
    Transplantation; 1985 Jan; 39(1):12-7. PubMed ID: 3155578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced immunologic responsiveness in multitransfused anemic nonuremic patients.
    Fehrman I; Ringdén O
    Transplant Proc; 1982 Jun; 14(2):341-3. PubMed ID: 6214063
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of random blood transfusions on immunoglobulin production by peripheral blood mononuclear cells from uraemic patients.
    Degiannis D; Mowat AM; Tsakiris D; Briggs JD; Junor BJ; Parrott DM
    Clin Exp Immunol; 1988 Jul; 73(1):155-9. PubMed ID: 3048812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the mixed leucocyte culture reaction by plasma from renal transplatn recipients.
    Singal DP; Younglai EV; Naipaul N
    Tissue Antigens; 1975 Feb; 5(1):19-25. PubMed ID: 124479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of mixed leukocyte culture using leukocytes from normal individuals, uremic patients, and allograft recipients.
    Agostino GJ; Kahan BD; Kerman RH
    Transplantation; 1982 Dec; 34(6):367-71. PubMed ID: 6218662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.
    Ibels LS; Stewart JH; Mahony JF; Neale FC; Sheil AG
    Q J Med; 1977 Apr; 46(182):197-214. PubMed ID: 325593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloantigen-blocking antibodies in sera from highly sensitized uremic patients: antibody class and relationship with lymphocytotoxins.
    Shoker AS; Okasha K; Sheridan DP; Kappel JE; Baltzan MA
    Transplantation; 1997 Sep; 64(6):853-60. PubMed ID: 9326410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological reactions involving leukocytes: II. Studies of a patient with multiple transfusion-induced allogeneic antibodies to leukocytes.
    Bilezikian SB; Tsan MF; Laleli YR; Bias WB; Hodkinson B; McIntyre PA
    Johns Hopkins Med J; 1976 Mar; 138(3):73-8. PubMed ID: 1255926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HLA, anti-human "Ia-like" and MLC blocking activity of human placental IgG.
    Jeannet M; Werner C; Ramirez E; Vassalli P; Faulk WP
    Transplant Proc; 1977 Jun; 9(2):1417-22. PubMed ID: 141758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.